Tesla, Inc.
$1.36T- Market cap
- $1.40T
- Debt
- +$8.15B
- Cash
- −$44.06B
Capital structure 99% equity / 1% debt · EV / Revenue 14.37x · EV / EBITDA 129.29x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $1.40T · View financials
Snapshot Sep 4, 4:00 PM ET
FY 2025 ·
Decision snapshot: TSLA stock price vs UNH: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at UNH's multiple
Needs UNH P/E.
Implied fair value · at TSLA's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple premium
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: TSLA FY 2025 (ended Dec 31, 2025) · UNH FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 99% equity / 1% debt · EV / Revenue 14.37x · EV / EBITDA 129.29x
Capital structure 82% equity / 18% debt · EV / Revenue 0.91x · EV / EBITDA 15.42x
TSLA carries the larger enterprise value at $1.36T against $406.74B; UNH trades on the lower EV / Revenue multiple (0.91x vs 14.37x); UNH on the lower EV / EBITDA (15.42x vs 129.29x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Tesla, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
UnitedHealth Group Incorporated · implied price per share
Bear
$316.48
Base
$378.28
Bull
$461.66
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.10x
0.78x
Net debt / EBITDA
Leverage against operating earnings
-3.41x
1.91x
Cash and equivalents
Liquid reserves on the balance sheet
$44.06B
$28.12B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Lucid Group, Inc.
TSLA vs LCID
FORD MOTOR CO
TSLA vs F
General Motors Co
TSLA vs GM
Enphase Energy, Inc.
TSLA vs ENPH
PLUG POWER INC
TSLA vs PLUG
COPART INC
TSLA vs CPRT
HUMANA INC
TSLA vs HUM
CENTENE CORP
TSLA vs CNC
CVS Health Corporation
TSLA vs CVS
Elevance Health, Inc.
TSLA vs ELV
MOLINA HEALTHCARE, INC.
TSLA vs MOH
$8.15B
$78.39B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe TSLA can reaccelerate growth and justify a materially higher earnings and sales multiple than UNH, then hold or add cautiously; otherwise, the data support reducing exposure because TSLA trades at extreme premiums despite negative revenue growth and only average quality scores.
TSLA trades at a massive premium to UNH across earnings, sales, and EBITDA multiples despite the comparison implying substantial downside. The current P/E-based implied price of $33.83 versus the actual $311.21 price highlights a -89.1% gap, while UNH implied range and DCF range are both far below the current quote.
Supporting Metrics